Literature DB >> 24092804

Nondisclosure of HIV status in a clinical trial setting: antiretroviral drug screening can help distinguish between newly diagnosed and previously diagnosed HIV infection.

Mark A Marzinke1, William Clarke, Lei Wang, Vanessa Cummings, Ting-Yuan Liu, Estelle Piwowar-Manning, Autumn Breaud, Sam Griffith, Susan Buchbinder, Steven Shoptaw, Carlos del Rio, Manya Magnus, Sharon Mannheimer, Sheldon D Fields, Kenneth H Mayer, Darrell P Wheeler, Beryl A Koblin, Susan H Eshleman, Jessica M Fogel.   

Abstract

In The HIV Prevention Trials Network 061 study, 155 human immunodeficiency virus (HIV)-infected men reported no prior HIV diagnosis; 83 of those men had HIV RNA levels of <1000 copies/mL at enrollment. Antiretroviral drug testing revealed that 65 of the 83 (78.3%) men were on antiretroviral treatment. Antiretroviral drug testing can help distinguish between newly diagnosed and previously diagnosed HIV infection.

Entities:  

Keywords:  HIV; MSM; antiretroviral; new diagnosis; self-report

Mesh：

Substances：

Year:  2013        PMID： 24092804      PMCID： PMC3864502          DOI： 10.1093/cid/cit672

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  10 in total

1.  Undisclosed antiretroviral drug use in a multinational clinical trial (HIV Prevention Trials Network 052).

Authors:  Jessica M Fogel; Lei Wang; Teresa L Parsons; San-San Ou; Estelle Piwowar-Manning; Ying Chen; Victor O Mudhune; Mina C Hosseinipour; Johnstone Kumwenda; James G Hakim; Suwat Chariyalertsak; Ravindre Panchia; Ian Sanne; Nagalingeswaran Kumarasamy; Beatriz Grinsztejn; Joseph Makhema; Jose Pilotto; Breno R Santos; Kenneth H Mayer; Marybeth McCauley; Theresa Gamble; Namandjé N Bumpus; Craig W Hendrix; Myron S Cohen; Susan H Eshleman
Journal:  J Infect Dis       Date:  2013-08-01       Impact factor: 5.226

Review 2.  Antiretroviral therapy for prevention is a combination strategy.

Authors:  Margaret L McNairy; Myron Cohen; Wafaa M El-Sadr
Journal:  Curr HIV/AIDS Rep       Date:  2013-06       Impact factor: 5.071

3.  Non-disclosure of HIV status in UK sexual health clinics--a pilot study to identify non-disclosure within a national unlinked anonymous seroprevalence survey.

Authors:  Ann Kathleen Sullivan; Emma J Savage; Catherine M Lowndes; George Paul; Gary Murphy; Simon Carne; David J Back; O Noel Gill
Journal:  Sex Transm Infect       Date:  2013-02-13       Impact factor: 3.519

4.  Unreported antiretroviral use by HIV-1-infected participants enrolling in a prospective research study.

Authors:  Erin M Kahle; Angela Kashuba; Jared M Baeten; Kenneth H Fife; Connie Celum; Andrew Mujugira; Max Essex; Guy De Bruyn; Anna Wald; Deborah Donnell; Grace John-Stewart; Sinead Delany-Moretlwe; Nelly R Mugo; Carey Farquhar; Jairam R Lingappa
Journal:  J Acquir Immune Defic Syndr       Date:  2014-02-01       Impact factor: 3.731

5.  Pretreatment antiretroviral exposure from recreational use.

Authors:  David J Grelotti; Elizabeth F Closson; Matthew J Mimiaga
Journal:  Lancet Infect Dis       Date:  2013-01       Impact factor: 25.071

6.  Adherence and acceptability in MTN 001: a randomized cross-over trial of daily oral and topical tenofovir for HIV prevention in women.

Authors:  Alexandra M Minnis; Sharavi Gandham; Barbra A Richardson; Vijayanand Guddera; Beatrice A Chen; Robert Salata; Clemensia Nakabiito; Craig Hoesley; Jessica Justman; Lydia Soto-Torres; Karen Patterson; Kailazarid Gomez; Craig W Hendrix
Journal:  AIDS Behav       Date:  2013-02

7.  The informal use of antiretrovirals for preexposure prophylaxis of HIV infection among gay men in Australia.

Authors:  Iryna B Zablotska; Garrett Prestage; John de Wit; Andrew E Grulich; Limin Mao; Martin Holt
Journal:  J Acquir Immune Defic Syndr       Date:  2013-03-01       Impact factor: 3.731

8.  Postexposure prophylaxis, preexposure prophylaxis or universal test and treat: the strategic use of antiretroviral drugs to prevent HIV acquisition and transmission.

Authors:  Jonathan Weber; Roger Tatoud; Sarah Fidler
Journal:  AIDS       Date:  2010-10       Impact factor: 4.177

9.  Correlates of HIV acquisition in a cohort of Black men who have sex with men in the United States: HIV prevention trials network (HPTN) 061.

Authors:  Beryl A Koblin; Kenneth H Mayer; Susan H Eshleman; Lei Wang; Sharon Mannheimer; Carlos del Rio; Steven Shoptaw; Manya Magnus; Susan Buchbinder; Leo Wilton; Ting-Yuan Liu; Vanessa Cummings; Estelle Piwowar-Manning; Sheldon D Fields; Sam Griffith; Vanessa Elharrar; Darrell Wheeler
Journal:  PLoS One       Date:  2013-07-26       Impact factor: 3.240

10.  Estimation of HIV incidence in a large, community-based, randomized clinical trial: NIMH project accept (HIV Prevention Trials Network 043).

Authors:  Oliver Laeyendecker; Estelle Piwowar-Manning; Agnes Fiamma; Michal Kulich; Deborah Donnell; Deb Bassuk; Caroline E Mullis; Craig Chin; Priscilla Swanson; John Hackett; William Clarke; Mark Marzinke; Greg Szekeres; Glenda Gray; Linda Richter; Michel W Alexandre; Suwat Chariyalertsak; Alfred Chingono; David D Celentano; Stephen F Morin; Michael Sweat; Thomas Coates; Susan H Eshleman
Journal:  PLoS One       Date:  2013-07-11       Impact factor: 3.240
  10 in total
  43 in total

1.  Determination of HIV Status in African Adults With Discordant HIV Rapid Tests.

Authors:  Jessica M Fogel; Estelle Piwowar-Manning; Kelsey Donohue; Vanessa Cummings; Mark A Marzinke; William Clarke; Autumn Breaud; Agnès Fiamma; Deborah Donnell; Michal Kulich; Jessie K K Mbwambo; Linda Richter; Glenda Gray; Michael Sweat; Thomas J Coates; Susan H Eshleman
Journal:  J Acquir Immune Defic Syndr       Date:  2015-08-01       Impact factor: 3.731

2.  Sexual Networks, Dyadic Characteristics, and HIV Acquisition and Transmission Behaviors Among Black Men Who Have Sex With Men in 6 US Cities.

Authors:  DeMarc A Hickson; Leandro A Mena; Leo Wilton; Hong-Van Tieu; Beryl A Koblin; Vanessa Cummings; Carl Latkin; Kenneth H Mayer
Journal:  Am J Epidemiol       Date:  2017-05-01       Impact factor: 4.897

3.  Public Health Benefit of Peer-Referral Strategies for Detecting Undiagnosed HIV Infection Among High-Risk Heterosexuals in New York City.

Authors:  Marya Gwadz; Charles M Cleland; David C Perlman; Holly Hagan; Samuel M Jenness; Noelle R Leonard; Amanda S Ritchie; Alexandra Kutnick
Journal:  J Acquir Immune Defic Syndr       Date:  2017-04-15       Impact factor: 3.731

4.  Racial Differences in Partnership Attributes, Typologies, and Risk Behaviors Among Men Who Have Sex With Men in Atlanta, Georgia.

Authors:  Darcy White; Jeremy A Grey; Pamina M Gorbach; Richard B Rothenberg; Patrick S Sullivan; Eli S Rosenberg
Journal:  Arch Sex Behav       Date:  2016-05-11

5.  Low-level Viremia early in HIV infection.

Authors:  Iris Chen; Vanessa Cummings; Jessica M Fogel; Mark A Marzinke; William Clarke; Matthew B Connor; Sam Griffith; Susan Buchbinder; Steven Shoptaw; Carlos Del Rio; Manya Magnus; Sharon Mannheimer; Darrell P Wheeler; Kenneth H Mayer; Beryl A Koblin; Susan H Eshleman
Journal:  J Acquir Immune Defic Syndr       Date:  2014-12-01       Impact factor: 3.731

6.  Disclosure of HIV Status and HIV Sexual Transmission Behaviors among HIV-Positive Black Men Who Have Sex with Men in the BROTHERS (HPTN 061) Study.

Authors:  Chukwuemeka N Okafor; Michael J Li; Christopher Hucks-Ortiz; Kenneth H Mayer; Steve Shoptaw
Journal:  J Urban Health       Date:  2020-10       Impact factor: 3.671

7.  Community viral load, antiretroviral therapy coverage, and HIV incidence in India: a cross-sectional, comparative study.

Authors:  Sunil Suhas Solomon; Shruti H Mehta; Allison M McFall; Aylur K Srikrishnan; Shanmugam Saravanan; Oliver Laeyendecker; Pachamuthu Balakrishnan; David D Celentano; Suniti Solomon; Gregory M Lucas
Journal:  Lancet HIV       Date:  2016-03-11       Impact factor: 12.767

8.  Antiretroviral Drug Use in a Cross-Sectional Population Survey in Africa: NIMH Project Accept (HPTN 043).

Authors:  Jessica M Fogel; William Clarke; Michal Kulich; Estelle Piwowar-Manning; Autumn Breaud; Matthew T Olson; Mark A Marzinke; Oliver Laeyendecker; Agnès Fiamma; Deborah Donnell; Jessie K K Mbwambo; Linda Richter; Glenda Gray; Michael Sweat; Thomas J Coates; Susan H Eshleman; Alfred H Chingono
Journal:  J Acquir Immune Defic Syndr       Date:  2017-02-01       Impact factor: 3.731

9.  Use of Antiretroviral Drug Testing to Assess the Accuracy of Self-reported Data from HIV-Infected People Who Inject Drugs.

Authors:  Jessica M Fogel; Yinfeng Zhang; Philip J Palumbo; Xu Guo; William Clarke; Autumn Breaud; Paul Richardson; Estelle Piwowar-Manning; Erica L Hamilton; Tran Viet Ha; Kostyantyn Dumchev; Zubairi Djoerban; Irving Hoffman; Brett Hanscom; William C Miller; Susan H Eshleman
Journal:  AIDS Behav       Date:  2019-08

10.  Evaluation of a Multidrug Assay for Monitoring Adherence to a Regimen for HIV Preexposure Prophylaxis in a Clinical Study, HIV Prevention Trials Network 073.

Authors:  Yinfeng Zhang; William Clarke; Mark A Marzinke; Estelle Piwowar-Manning; Geetha Beauchamp; Autumn Breaud; Craig W Hendrix; Gavin A Cloherty; Lynda Emel; Scott Rose; Lisa Hightow-Weidman; Marc Siegel; Steven Shoptaw; Sheldon D Fields; Darrell Wheeler; Susan H Eshleman
Journal:  Antimicrob Agents Chemother       Date:  2017-06-27       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.